References
- Davenport H. W. Gastric mucosal injury by fatty and acetylsalicylic acids. Gastroenterology 1964; 46: 245–53
- Davenport H. W. Damage to the gastric mucosa: effects of salicylates and stimulation. Gastroenterology 1965; 49: 184–96
- Davenport H. W. Salicylate damage to the gastric mucosal barrier. New Engl J Med 1967; 276: 1307–12
- Domschke S., Domschke W. Gastroduodenal damage due to drugs alcohol and smoking. Clin Gastroenterol 1984; 13: 45–36
- Bugat R., Thompson M. R., Aures D., Grossman M. I. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology 1976; 71: 754–9
- Grossman M. I., Matsumota K. K., Lichter R. J. Fecal blood loss by oral and intravenous administration of various salicylates. Gastroenterology 1961; 40: 383–8
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol 1971; 231: 232–5
- Whittle BJR, Higgs G.A., Eakins K.E., Moncada S., Vane J. R. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980; 284: 271–3
- Peskar B. M., Weiler H., Meyer C. H. Inhibition of prostaglandin production in the gastrointestinal tract by anti-inflammatory drugs. Adv Inflamm Res 1984; 6: 39–50
- Whittle BJR, Boughton-Smith N.K., Moncada S., Vane J. R. Actions of prostacyclin (PGI2) and its product 6-oxo-PGF1α on the rat gastric mucosa. in vivo and in vitro. Prostaglandins 1978; 15: 955–68
- Ligumsky M., Golanska E. M., Hansen D. G., Kaufmann G. L. Aspirin can inhibit gastric mucosal cyclooxygenase without causing lesions in the rat. Gastroenterology 1983; 84: 756–61
- Whittle BJR. Temporal relationship between cyclooxygenase inhibition as measured by prostacyclin biosynthesis and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94–8
- Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979; 77: 761–7
- Ito S., Lazc E. R., Rutten M. J., Critchlow J., Silen W. Rapid repair of injured gastric mucosa. Scand J Gastroenterol 1985; 19((suppl. 101))87–95
- Rask-Madsen J. The role of eicosanoids in the gastrointestinal tract. Scand J Gastroenterol 1987; 22((suppl. 127))7–19
- Garner A., Allen A., Row P. H. Gastroduodenal mucosal defence mechanisms and the action of non-steroidal anti-inflammatory agents. Scand J Gastroenterol 1987; 22((suppl. 127))29–34
- Whittle BJR, Oren-Wolman N., Guth P. H. Gastric vasoconstrictor actions of leukotriene C4, PGF2α and thromboxane mimetic U-44619 on rat submucosal microcirculation. in vivo. Am J Physiol 1985; 248: G580–6
- Szabo S. Mechanisms of mucosal injury in the stomach and duodenum: time-sequence analysis of morphologic, functional, biochemical and histochemical studies. Scand J Gastroenterol 1987; 22((suppl. 127))21–8
- Reinhart W. H., Müller O., Halter F. Influence of long-term 16 16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa. Gastroenterology 1983; 85: 1003–10
- Fich A., Arber N., Sestieri M, et al. Effect of misoprostol and cimetidine on gastric cell labelling index. Gastroenterology 1985; 89: 57–61
- Baumgartner A., Koelz H. R., Halter F. Indomethacin and turnover of gastric mucosal cells in the rat. Am J Physiol 1985; 250: G830–5
- St John DJB, Yeoman D.D., McDermott F.T., der Baer WGRM. Adaptation of the gastric mucosa to repeated administration of aspirin in the rat. Am J Dig Dis 1973; 18: 881–6
- Graham D. Y., Smith J. L., Dobbs S. M. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1–6